Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 3
2010 2
2013 1
2014 1
2015 1
2019 1
2020 12
2021 8
2022 12
2023 2
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

43 results

Results by year

Filters applied: . Clear all
Page 1
Future Directions in the Treatment of Osteosarcoma.
Smrke A, Anderson PM, Gulia A, Gennatas S, Huang PH, Jones RL. Smrke A, et al. Among authors: gennatas s. Cells. 2021 Jan 15;10(1):172. doi: 10.3390/cells10010172. Cells. 2021. PMID: 33467756 Free PMC article. Review.
Adjuvant Imatinib in Patients with GIST Harboring Exon 9 KIT Mutations: Results from a Multi-institutional European Retrospective Study.
Vincenzi B, Napolitano A, Fiocco M, Mir O, Rutkowski P, Blay JY, Reichardt P, Joensuu H, Fumagalli E, Gennatas S, Hindi N, Nannini M, Spalato Ceruso M, Italiano A, Grignani G, Brunello A, Gasperoni S, De Pas T, Badalamenti G, Pantaleo MA, van Houdt WJ, IJzerman NS, Steeghs N, Gelderblom H, Desar IME, Falkenhorst J, Silletta M, Sbaraglia M, Tonini G, Martin-Broto J, Hohenberger P, Le Cesne A, Jones RL, Dei Tos AP, Gronchi A, Bauer S, Casali PG. Vincenzi B, et al. Among authors: gennatas s. Clin Cancer Res. 2022 Apr 14;28(8):1672-1679. doi: 10.1158/1078-0432.CCR-21-1665. Clin Cancer Res. 2022. PMID: 34615721 Free PMC article.
Integrated genomics point to immune vulnerabilities in pleural mesothelioma.
Nastase A, Mandal A, Lu SK, Anbunathan H, Morris-Rosendahl D, Zhang YZ, Sun XM, Gennatas S, Rintoul RC, Edwards M, Bowman A, Chernova T, Benepal T, Lim E, Taylor AN, Nicholson AG, Popat S, Willis AE, MacFarlane M, Lathrop M, Bowcock AM, Moffatt MF, Cookson WOCM. Nastase A, et al. Among authors: gennatas s. Sci Rep. 2021 Sep 27;11(1):19138. doi: 10.1038/s41598-021-98414-w. Sci Rep. 2021. PMID: 34580349 Free PMC article.
Author Correction: Integrated genomics point to immune vulnerabilities in pleural mesothelioma.
Nastase A, Mandal A, Lu SK, Anbunathan H, Morris-Rosendahl D, Zhang YZ, Sun XM, Gennatas S, Rintoul RC, Edwards M, Bowman A, Chernova T, Benepal T, Lim E, Taylor AN, Nicholson AG, Popat S, Willis AE, MacFarlane M, Lathrop M, Bowcock AM, Moffatt MF, Cookson WOCM. Nastase A, et al. Among authors: gennatas s. Sci Rep. 2022 Mar 21;12(1):4779. doi: 10.1038/s41598-022-08800-1. Sci Rep. 2022. PMID: 35314756 Free PMC article. No abstract available.
A Timely Oral Option: Single-Agent Vinorelbine in Desmoid Tumors.
Gennatas S, Chamberlain F, Smrke A, Stewart J, Hayes A, Roden L, Messiou C, Kowa JY, Estival A, Chauhan D, Thway K, Fisher C, van der Graaf WTA, Jones RL, Benson C. Gennatas S, et al. Oncologist. 2020 Dec;25(12):e2013-e2016. doi: 10.1002/ONCO.13516. Epub 2020 Oct 2. Oncologist. 2020. PMID: 32918789 Free PMC article.
Low-grade Fibromyxoid Sarcoma: Treatment Outcomes and Efficacy of Chemotherapy.
Chamberlain F, Engelmann B, Al-Muderis O, Messiou C, Thway K, Miah A, Zaidi S, Constantinidou A, Benson C, Gennatas S, Jones RL. Chamberlain F, et al. Among authors: gennatas s. In Vivo. 2020 Jan-Feb;34(1):239-245. doi: 10.21873/invivo.11766. In Vivo. 2020. PMID: 31882484 Free PMC article.
43 results